Business
Sanara MedTech Inc. Announces Recent Testing Results Showing That BIAKŌS(TM) Antimicrobial Skin and Wound Cleanser Is Effective Against SARS-CoV-2, MRSA, and VRE
FORT WORTH, TX / ACCESSWIRE / June 3, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a
About this update from Sanara Medtech Inc.
[{"type":"text","content":"FORT WORTH, TX / ACCESSWIRE / June 3, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (\"Sanara\" or the \"Company\") (OTCQB:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, announced today the results of testing performed with the Company's BIAKŌS™ Antimicrobial Skin and Wound Cleanser against Severe Acute Respiratory Syndrome Coronavirus 2 (\"SARS-CoV-2\"), the virus that causes Coronavirus Disease 2019 (\"COVID-19\"). This is in addition to BIAKŌS's™ previously known efficacy in the presence of Methicillin-resistant Staphylococcus aureus (\"MRSA\") and Vancomycin-resistant enterococci (\"VRE\").BIAKŌS™ Antimicrobial Skin & Wound Cleanser BackgroundBIAKŌS™ Antimicrobial Skin & Wound Cleanser is currently cleared by the FDA for mechanical cleansing and removal of debris, dirt and foreign materials, including microorganisms from wounds such as stage I-IV pressure ulcers, diabetic foot ulcers, post-surgical wounds, first- and second-degree burns, grafted and donor sites.Testing Results Against SARS-CoV-2In May 2020, Sanara worked with the World Reference Center for Emerging Viruses and Arboviruses at the University of Texas Medical Branch at Galveston to determine if BIAKŌS™ has the ability to inactivate SARS-CoV-2 in solution. Testing resulted in a 99.96% reduction (below the limit of detection) of SARS-CoV-2 within 30 seconds in the presence of BIAKŌS.An additional recent study conducted by Analytical Lab Group, an industry leader in specialty contract lab testing, determined that BIAKŌS™ is also effective against human coronavirus in solution achieving a ≥99.96% reduction in viral load. According to the study director, \"There was no evidence of viral infectivity so we would say the virus was completely inactivated.\"Testing Results Against MRSA and VREPrevious testing has shown that BIAKŌS™ Antimicrobial Skin and Wound Cleanser achieves over a 99.9999% kill in solution within 30 seconds and a complete kill within 1 minute against MRSA and VRE, indicating that BIAKŌS™ is a wound and skin cleanser that remains effective even when these microorganisms are present.Benefits of BIAKŌS™ As a Cleanser Against SARS-CoV-2, MRSA, and VRE BIAKŌS™ does not contain alcohol which can dry out skin and lead to cracking and opening of the dermis, a true benefit when cleansing...